Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer

Takhar, Arunjit Singh; Ney, Alex; Patel, Meera; Sharma, Anup
May 2013
BMJ Case Reports;May2013, p1
Academic Journal
No abstract available.


Related Articles

  • Cyclophosphamide/doxorubicin/paclitaxel.  // Reactions Weekly;1/13/2007, Issue 1134, p12 

    The article discusses two cases of middle-aged women who developed extramedullary haematopoiesis after neoadjuvant chemotherapy with cyclophosphamide, doxorubicin, and paclitaxel for breast cancer. The patients were hospitalized for axillary lymph node dissection and mastectomy following...

  • CITATIONS AND CLINICIANS' NOTES: IMAGING, STAGING, AND SCREENING -- STAGING.  // Current Medical Literature: Breast Cancer;2004, Vol. 16 Issue 4, p99 

    Discusses two studies on breast cancer screening. Variability in axillary lymph node dissection for breast cancer; Use of a periareolar injection of radiocolloid in sentinel lymph node biopsy for patients with neoadjuvant chemotherapy-treated breast carcinoma.

  • MEME KANSERLÄ° HASTALARDA NEOADJUVAN KEMOTERAPÄ° ÇˌKARËŒLAN AKSÄ°LLER LENF NODU SAYËŒSËŒNËŒ AZALTËŒR MËŒ? Gülben, Kaptan; Berberoglu, Ugur // Meme Sagligi Dergisi / Journal of Breast Health;2010, Vol. 6 Issue 3, p118 

    Introduction: Traditionally, it is suggested to be retrieved a minimum of 10 lymph nodes in an axillary dissection for accurate staging of axilla. The aim of this study is to review whether neoadjuvant chemotherapy reduces the total number of lymph nodes retrieved in axillary dissection....

  • Complete axillary conversion after neoadjuvant chemotherapy in locally advanced breast cancer: a step towards conserving axilla? Arimappamagan, A.; Kadambari, D.; Srinivasan, K.; Krishnan, R.; Elangovan, S.; Reddy, K.S.N. // Indian Journal of Cancer;Jan-Mar2004, Vol. 41 Issue 1, p13 

    Objectives: This study was designed to assess the clinical, sonographic and histopathological response of axillary lymph node metastasis to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Material and Methods: Forty patients with locally...

  • Evaluation of Sentinel Node Biopsy in Locally Advanced Breast Cancer PatientsWho Become Clinically Node-Negative after Neoadjuvant Chemotherapy: A Preliminary Study. Thomas, Shaji; Prakash, Apurva; Goyal, Vinay; Popli, Manju Bala; Agarwal, Shilpi; Choudhury, Monisha // International Journal of Breast Cancer;2011, p1 

    Introduction. Controversy continues over the appropriate timing of sentinel lymph node (SLN) biopsy in locally advanced breast cancer (LABC) patients receiving neoadjuvant chemotherapy. We evaluated the feasibility and accuracy of SLN biopsy in LABC patients with cytology-proven axillary nodal...

  • Oncology.  // European Journal of Nuclear Medicine;2000, Vol. 27 Issue 8, p928 

    Presents abstracts about oncology presented at the Congress of the European Association of Nuclear Medicine held September 2-6, 2000 in Paris, France. 'Evaluation of Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Using 99mTc-MIBI Breast Scintigraphy,' by E. Prats, J.I....

  • Does FDG PET/CT negativity after neoadjuvant therapy in breast cancer imply absence of residual malignancy? Torri, Vamsee; Ghesani, Munir // Hem/Onc Today;8/10/2008, Vol. 9 Issue 14, p6 

    The article describes the case of a 37-year-old woman who has bilateral synchronous invasive lobular breast cancer. A mass in the left breast and axillary lymph node were found during her initial mammogram. The patient underwent neoadjuvant chemotherapy with doxorubicin and cyclophosphamide...

  • AXILLARY RESPONSE TO NEO-ADJUVANT CHEMOTHERAPY: DECREASE IN NUMBER OF LYMPH NODES. Aksaz, Erol; Öncel, Tayanç; Yazıcı, Turay; Aydemir, Adil; Bayer, Sibel; İpek, Nuray // Meme Sagligi Dergisi / Journal of Breast Health;2012, Vol. 8 Issue 3, p134 

    Background: NAC (Neo-adjuvant chemotherapy) is the standard treatment method for locally advanced breast cancers. NAC is used to decrease of stage in locally advanced cancer and/or preparation for breast conserving surgery. Evaluation of patients' responses to NAC is vital for both prognosis and...

  • MRI and F-FDG PET/CT in monitoring the response to neoadjuvant chemotherapy: is it necessary to appropriately select the patients? Evangelista, Laura; Ruggieri, Domenico; Pescarini, Luigi; Saladini, Giorgio // European Journal of Nuclear Medicine & Molecular Imaging;Aug2014, Vol. 41 Issue 8, p1511 

    The article presents the authors' perspective on a study concerning neoadjuvant or preoperative chemotherapy (NAC) which is considered the standard of care in the treatment of locally advanced breast cancer. They outline the potential benefits of the therapy such as the reduction in size of the...

  • Are we ready for an early evaluation of the response of axillary lymph node metastases to neoadjuvant therapy? Gilardi, Laura; De Cicco, Concetta; Paganelli, Giovanni // European Journal of Nuclear Medicine & Molecular Imaging;Nov2011, Vol. 38 Issue 11, p2096 

    A letter to the editor is presented in response to the article "FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients," by C. Rousseau and colleagues in the 2011 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics